Ontology highlight
ABSTRACT: Importance
More than 1.3 million people in the United States have a hematologic malignant tumor currently or in remission. Previous studies have demonstrated an increased risk of secondary neoplasms in patients with hematologic malignant tumors, but research specifically on the risk of head and neck solid tumors in patients with prior hematologic malignant tumors is limited.Objectives
To examine a possible association between prior hematologic malignant tumors and risk of head and neck cancer and to assess the overall survival (OS) among these patients.Design, setting, and participants
This retrospective analysis used the Veterans Affairs (VA) Corporate Data Warehouse (CDW) to identify patients with diagnoses of hematologic malignant tumors and head and neck cancers
SUBMITTER: Mowery A
PROVIDER: S-EPMC6499130 | biostudies-literature | 2019 Dec
REPOSITORIES: biostudies-literature